Farid, S., Ahmed, A., Sweilam, S., Rashed, L. (2015). IFN-Stimulated Genes Upregulation Pattern in Chronic Hepatitis C. The Egyptian Journal of Hospital Medicine, 61(1), 389-405. doi: 10.12816/0017692
Saadia Farid; Amal Ahmed; Samya Sweilam; Laila Rashed. "IFN-Stimulated Genes Upregulation Pattern in Chronic Hepatitis C". The Egyptian Journal of Hospital Medicine, 61, 1, 2015, 389-405. doi: 10.12816/0017692
Farid, S., Ahmed, A., Sweilam, S., Rashed, L. (2015). 'IFN-Stimulated Genes Upregulation Pattern in Chronic Hepatitis C', The Egyptian Journal of Hospital Medicine, 61(1), pp. 389-405. doi: 10.12816/0017692
Farid, S., Ahmed, A., Sweilam, S., Rashed, L. IFN-Stimulated Genes Upregulation Pattern in Chronic Hepatitis C. The Egyptian Journal of Hospital Medicine, 2015; 61(1): 389-405. doi: 10.12816/0017692
IFN-Stimulated Genes Upregulation Pattern in Chronic Hepatitis C
1Departments of Tropical Medicine,National Hepatology and Tropical Medicine Research Institute and Faculty of Medicine, Cairo University
2Departments of Biochemistry ,National Hepatology and Tropical Medicine Research Institute and Faculty of Medicine, Cairo University
3Departments of Medical Biochemistry National Hepatology and Tropical Medicine Research Institute and Faculty of Medicine, Cairo University
Abstract
Background: The development of effective tools for the large-scale analysis of gene expression has provided new insights into the involvement of gene networks and regular pathways in various disease processes. The chemokine receptor CXCR3 is a G protein-coupled receptor found predominantly on T cells that is activated by three ligands as follow: CXCL9 (Mig), CXCL10 (IP-10) and CXCL11 (I-TAC), and play a key role in immune and inflammatory responses by promoting recruitment and activation of different subpopulations of leukocytes. Aim of the work: The study is a logical functional approach for the development of serum markers chemokines that bind to CXC chemokine receptor 3 to determine whether they play a role in the future of immune system to clear HCV, these chemokines: CXCL9, CXCL10 and CXCL11. Patients and methods: 131 male and female patients with chronic hepatitis C virus (CHCV) infection, their age ranges between 22 and 55 years, selected from the National Hepatology and Tropical Medicine Research Institute. The included patients were divided to two groups, the first group: 80 patients were investigated for the predictive values of CXCL9,10,11 and CXCR3 chemokines in peripheral blood mononuclear cells (PBMCs), the second group were fifty one patients analyzed for the expression of surface markers on CD8+T cells. Twenty healthy individuals were included to serve as controls for each group. All the patients and controls were subjected to the following: history, clinical examination, abdominal ultrasonography and collection of blood samples for routine laboratory investigation and serological assay. Results: Chemokine CXCL9, CXCL10, CXCL11 and their receptor CXCR3 expression levels are induced in PBMCs during CHCV infection, associated with increased the expression levels of CD8+T cells in CHCV patients. Conclusion: The interaction between chemokines and their receptors is essential in recruiting HCV-specific T cells to control the infection. Recommendations: The regulationof chemokines and their receptors could be a future potential therapeutic target to decrease liver inflammation and to increase specific T cell migration to the infected liver, the blocking of chemokines and chemokine receptor engagement is a therapeutic strategy that should be explored in the near future for non-responders to current anti-HCV therapy.
View on SCiNiTO
Top